NasdaqGM - Delayed Quote USD
908 Devices Inc. (MASS)
5.62
-0.17
(-2.94%)
At close: May 9 at 4:00:02 PM EDT
5.50
-0.12
(-2.14%)
After hours: May 9 at 6:33:02 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
59,631
59,631
50,229
46,852
42,206
Cost of Revenue
29,775
29,775
24,907
20,829
18,973
Gross Profit
29,856
29,856
25,322
26,023
23,233
Operating Expense
79,131
79,131
67,973
61,405
45,302
Operating Income
-49,275
-49,275
-42,651
-35,382
-22,069
Net Non Operating Interest Income Expense
4,494
4,494
6,279
1,902
62
Other Income Expense
-27,707
-27,707
-238
-83
-162
Pretax Income
-72,488
-72,488
-36,610
-33,563
-22,169
Tax Provision
-282
-282
-211
0
--
Net Income Common Stockholders
-72,206
-72,206
-36,399
-33,563
-22,169
Diluted NI Available to Com Stockholders
-72,206
-72,206
-36,399
-33,563
-22,169
Basic EPS
-2.12
--
-1.13
-1.07
-0.79
Diluted EPS
-2.12
--
-1.13
-1.07
-0.79
Basic Average Shares
34,076.32
--
32,239.39
31,492.53
27,957.90
Diluted Average Shares
34,076.32
--
32,239.39
31,492.53
27,957.90
Total Operating Income as Reported
-76,718
-76,718
-42,758
-35,382
-22,069
Total Expenses
108,906
108,906
92,880
82,234
64,275
Net Income from Continuing & Discontinued Operation
-72,206
-72,206
-36,399
-33,563
-22,169
Normalized Income
-44,869.76
-44,869.76
-36,292.62
-33,563
-22,169
Interest Income
4,494
4,494
6,480
2,031
548
Interest Expense
0
0
201
129
486
Net Interest Income
4,494
4,494
6,279
1,902
62
EBIT
-72,488
-72,488
-36,409
-33,434
-21,683
EBITDA
-67,806
-67,806
-34,025
-31,820
-20,758
Reconciled Cost of Revenue
29,775
29,775
24,907
20,829
18,973
Reconciled Depreciation
4,682
4,682
2,384
1,614
925
Net Income from Continuing Operation Net Minority Interest
-72,206
-72,206
-36,399
-33,563
-22,169
Total Unusual Items Excluding Goodwill
-27,443
-27,443
-107
--
--
Total Unusual Items
-27,443
-27,443
-107
--
--
Normalized EBITDA
-40,363
-40,363
-33,918
-31,820
-20,758
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-106.76
-106.76
-0.62
0
0
12/31/2021 - 12/18/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
STIM Neuronetics, Inc.
4.4300
-4.73%
LUCD Lucid Diagnostics Inc.
1.1300
-5.04%
RPID Rapid Micro Biosystems, Inc.
3.0800
+25.71%
KIDS OrthoPediatrics Corp.
22.04
-4.51%
RBOT Vicarious Surgical Inc.
8.62
-2.49%
BVS Bioventus Inc.
6.68
-1.76%
SGHT Sight Sciences, Inc.
3.0800
+1.65%
INBS Intelligent Bio Solutions Inc.
1.2100
+0.83%
PACB Pacific Biosciences of California, Inc.
1.1200
-6.67%
DCTH Delcath Systems, Inc.
14.84
+3.38%